BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37723273)

  • 1. Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals.
    Pearson-Stuttard J; Banerji T; Capucci S; de Laguiche E; Faurby MD; Haase CL; Sommer Matthiessen K; Near AM; Tse J; Zhao X; Evans M
    Int J Obes (Lond); 2023 Dec; 47(12):1239-1246. PubMed ID: 37723273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study.
    Divino V; Ramasamy A; Anupindi VR; Eriksen KT; Olsen AH; DeKoven M; Meincke HH
    J Manag Care Spec Pharm; 2021 Feb; 27(2):210-222. PubMed ID: 33307936
    [No Abstract]   [Full Text] [Related]  

  • 3. Eight-year trends in obesity-related complications and health care cost progression in a US population with obesity: A retrospective cohort study.
    Evans M; Anupindi VR; DeKoven M; de Laguiche E; Divino V; Faurby MD; Haase CL; Sommer Matthiessen K; Pearson-Stuttard J
    Diabetes Obes Metab; 2023 Feb; 25(2):536-544. PubMed ID: 36263756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States.
    Li Q; Blume SW; Huang JC; Hammer M; Ganz ML
    J Med Econ; 2015; 18(12):1020-8. PubMed ID: 26134917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of obesity in Kuwait: a micro-costing study evaluating the burden of obesity-related comorbidities.
    Al-Sabah S; ElShamy A; Jois S; Low K; Gras A; Gulnar EP
    J Med Econ; 2023; 26(1):1368-1376. PubMed ID: 37853705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications.
    Al-Omar HA; Alshehri A; Abanumay A; Alabdulkarim H; Alrumaih A; Eldin MS; Alqahtani SA
    Adv Ther; 2023 Apr; 40(4):1430-1443. PubMed ID: 36680731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database.
    MedSci KKF; Schnecke V; Haase CL; Harder-Lauridsen NM; Rathor N; Sommer K; Morgen CS
    Diabetes Obes Metab; 2023 Sep; 25(9):2669-2679. PubMed ID: 37283064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-related complications, healthcare resource use and weight loss strategies in six European countries: the RESOURCE survey.
    Evans M; de Courcy J; de Laguiche E; Faurby M; Haase CL; Matthiessen KS; Moore A; Pearson-Stuttard J
    Int J Obes (Lond); 2023 Aug; 47(8):750-757. PubMed ID: 37258646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Impact of Obesity in Turkey: A Micro-Costing Analysis.
    Gogas Yavuz D; Akhtar O; Low K; Gras A; Gurser B; Yilmaz ES; Basse A
    Clinicoecon Outcomes Res; 2024; 16():123-132. PubMed ID: 38476579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity.
    Boye KS; Lage MJ; Terrell K
    J Diabetes Complications; 2020 Dec; 34(12):107730. PubMed ID: 32943301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
    Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
    Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of obesity in 4 south-eastern European countries associated with obesity-related co-morbidities.
    Athanasakis K; Bala C; Kokkinos A; Simonyi G; Karoliová KH; Basse A; Bogdanovic M; Kang M; Low K; Gras A
    BMC Health Serv Res; 2024 Mar; 24(1):354. PubMed ID: 38504302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
    Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M
    BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis.
    Colao A; Lucchese M; D'Adamo M; Savastano S; Facchiano E; Veronesi C; Blini V; Degli Esposti L; Sbraccia P
    BMJ Open; 2017 Feb; 7(2):e013899. PubMed ID: 28237961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.
    Pelletier EM; Smith PJ; Boye KS; Misurski DA; Tunis SL; Minshall ME
    Appl Health Econ Health Policy; 2008; 6(2-3):103-12. PubMed ID: 19231904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.